153 related articles for article (PubMed ID: 12517247)
1. Eprosartan for the treatment of hypertension.
Ruilope L; Jäger B
Expert Opin Pharmacother; 2003 Jan; 4(1):107-14. PubMed ID: 12517247
[TBL] [Abstract][Full Text] [Related]
2. The clinical profile of the angiotensin II receptor blocker eprosartan.
Hedner T
J Hypertens Suppl; 2002 Jun; 20(5):S33-8. PubMed ID: 12184062
[TBL] [Abstract][Full Text] [Related]
3. Clinical profile of eprosartan.
Puig JG; López MA; Bueso TS; Bernardino JI; Jiménez RT;
Cardiovasc Drugs Ther; 2002 Dec; 16(6):543-9. PubMed ID: 12766389
[TBL] [Abstract][Full Text] [Related]
4. Management of hypertension: the advent of a new angiotensin II receptor antagonist.
Hedner T
J Hypertens Suppl; 1999 Jun; 17(2):S21-5. PubMed ID: 10465063
[TBL] [Abstract][Full Text] [Related]
5. Potential of the angiotensin II receptor 1 blocker eprosartan in the management of patients with hypertension or heart failure.
Hollenberg NK
Curr Hypertens Rep; 2001 Sep; 3 Suppl 1():S25-8. PubMed ID: 11580885
[TBL] [Abstract][Full Text] [Related]
6. Potential renoprotective effects of the angiotensin receptor blocker eprosartan: a review of preliminary renal studies.
Rayner B; Jaeger B; Verboom CN; Pascoe M
Cardiovasc J S Afr; 2004; 15(1):32-7. PubMed ID: 14997235
[TBL] [Abstract][Full Text] [Related]
7. Introduction: The pharmacological profile of eprosartan--implications for cerebrovascular and cardiovascular risk reduction.
de la Sierra A; Ram CV
Curr Med Res Opin; 2007 Nov; 23 Suppl 5():S1-3. PubMed ID: 18093407
[TBL] [Abstract][Full Text] [Related]
8. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
[TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of eprosartan in combination with hydrochlorothiazide.
Böhm M; Sachse A
Drug Saf; 2002; 25(8):599-611. PubMed ID: 12113644
[TBL] [Abstract][Full Text] [Related]
10. Eprosartan: a review of its use in the management of hypertension.
Robins GW; Scott LJ
Drugs; 2005; 65(16):2355-77. PubMed ID: 16266204
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of eprosartan in severe hypertension. Eprosartan Multinational Study Group.
Sega R
Blood Press; 1999; 8(2):114-21. PubMed ID: 10451039
[TBL] [Abstract][Full Text] [Related]
12. Eprosartan: a review of its use in hypertension.
Plosker GL
Drugs; 2009; 69(17):2477-99. PubMed ID: 19911859
[TBL] [Abstract][Full Text] [Related]
13. A double blind randomized trial to compare the effects of eprosartan and enalapril on blood pressure, platelets, and endothelium function in patients with essential hypertension.
Leu HB; Charng MJ; Ding PY
Jpn Heart J; 2004 Jul; 45(4):623-35. PubMed ID: 15353873
[TBL] [Abstract][Full Text] [Related]
14. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
[TBL] [Abstract][Full Text] [Related]
15. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of eprosartan, a new angiotensin II receptor blocker.
Shusterman NH
Am Heart J; 1999 Sep; 138(3 Pt 2):238-45. PubMed ID: 10467219
[TBL] [Abstract][Full Text] [Related]
17. Eprosartan: a review of its use in the management of hypertension.
Plosker GL; Foster RH
Drugs; 2000 Jul; 60(1):177-201. PubMed ID: 10929934
[TBL] [Abstract][Full Text] [Related]
18. Effect of eprosartan and enalapril in the treatment of elderly hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Argenziano L; Trimarco B
Curr Med Res Opin; 1999; 15(1):9-14. PubMed ID: 10216806
[TBL] [Abstract][Full Text] [Related]
19. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
[TBL] [Abstract][Full Text] [Related]
20. Clinical profile of eprosartan: a different angiotensin II receptor blocker.
Blankestijn PJ; Rupp H
Cardiovasc Hematol Agents Med Chem; 2008 Oct; 6(4):253-7. PubMed ID: 18855637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]